The Society of Biotherapeutic Approaches (SBA). The society is now a section of the Nonprofit Organization Linking Setouchi Innate Immune Network: LSIN, which was established in March 2006.
Date of Founding
September 1, 1997.
Purpose and Activities
The purpose of the society is to facilitate good communication among basic researchers and clinicians working on biotherapeutics and to perform clinical trials with adequate informed consent in an appropriate and professional manner.
The society holds an annual meeting and submits its proceedings to an international journal.
Board of Directors (14 directors)
Hiroyuki Inagawa, Kitaro Futami, Takeo Fukushima, Shigenori Gotoh, Hitoshi Hori, Mitsuo Katano, Masahide Kuroki, Kimiko Makino, Shin-ichiro Miyake, Shingo Miyamoto, Satoshi Ohno, Shinya Ohshiro, Hidechika Okada, Senji Shirasawa, Gen-ichiro Soma, Hiroshi Terada
President, 2014 18th Annual Meeting of the SBA
President, 2015 19th Annual Meeting of the SBA
President, 2016 20th Annual Meeting of the SBA
The SBA Administration Office
Department of Obstetrics and Gynecology, The Faculty of Medicine, Fukuoka University,
7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan
Telephone: 81-92-801-1011 (Ext. 3505) FAX: 81-92-865-4114
Annual membership fee: ￥5,000. (Student: ￥2,000). All individuals. There is no organizational membership system.
Annual Meeting and Proceedings
The society holds its annual meeting once a year, generally in December.
After the meeting, the society submits the proceedings of the annual meeting to an international journal “Anticancer Research” as The Proceedings of the Annual Meeting of the SBA. The full papers accepted after the peer reviewing have been published in the journal.
Specialty Areas of the Members of the SBA
Organic chemistry, biochemistry, molecular biology, molecular oncology, growth factors and cytokines, signal transduction, cell cycle, apoptosis, invasion and metastasis, angiogenesis, cell biology, immunology, microbiology, experimental animals and genetically engineered animals, pharmacology and pharmacy, diagnostics, proteomics, cytological diagnosis, preventive medicine, surgical therapy, chemotherapy, molecular target therapy, immunotherapy, gene therapy, radiotherapy and thermotherapy, regenerative medicine, therapy for intractable diseases including advanced cancer.